Piper Sandler Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96

Colgate-Palmolive Company

Colgate-Palmolive Company

CL

0.00

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE: CL) with a Overweight and raises the price target from $92 to $96.